APA (7th ed.) Citation

SF, V., S, O., J, B., JY, K., OS, K., C, W., . . . BK, S. (2025). Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects. ACS central science, 11(5), 770. https://doi.org/10.1021/acscentsci.5c00052

Chicago Style (17th ed.) Citation

SF, Vigneron, et al. "Docking 14 Million Virtual Isoquinuclidines Against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects." ACS Central Science 11, no. 5 (2025): 770. https://doi.org/10.1021/acscentsci.5c00052.

MLA (9th ed.) Citation

SF, Vigneron, et al. "Docking 14 Million Virtual Isoquinuclidines Against the μ and κ Opioid Receptors Reveals Dual Antagonists-Inverse Agonists with Reduced Withdrawal Effects." ACS Central Science, vol. 11, no. 5, 2025, p. 770, https://doi.org/10.1021/acscentsci.5c00052.